Delivery Order SPE2DB22D9206-SPE2DB25FV5ES
Award Date 9/24/25
Potential Completion Date 9/25/25
Potential Value $13K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- On September 8, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). The contract, valued at $8,622.72, carries a firm fixed-price structure with an ultimate completion date of September 9, 2025. The delivery order carries no set-aside designation and represents performance at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on September 15, 2025, with completion targeted for September 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price delivery order contract with no set-aside designation. The order will be fulfilled from the contractor's Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. on September 3, 2025, for the supply of Xtandi 40 mg capsules (120-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order for delivery to Park Ridge, IL. The contract utilizes a firm fixed-price structure with an ultimate completion date of September 4, 2025, and no set-aside designation...
- On September 26, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $51,736.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, identified as 4569610863, is for the supply of Xtandi 40 mg capsules in quantities of 120 units, with an ultimate completion date of September 29, 2025. This award carries no set-aside designation and represents a direct delivery order...
- The Defense Logistics Agency awarded a $8,622.72 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 8, 2025, for the supply of Xtandi 40 mg capsules (quantity: 120 units). The contract, which is set to be completed by September 9, 2025, represents a discrete delivery against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA. This delivery order carries no set-aside designation and will be performed at the contractor's facility in Park Ridge,...
- On August 27, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $5,911.35 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120-count units). This firm fixed-price delivery order, which has an ultimate completion date of August 28, 2025, was issued without a set-aside designation. The contract is being performed at the contractor's Park Ridge facility and...
- On August 14, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $12,508.77 to DMS Pharmaceutical Group Inc. for the supply of Xtandi 80 mg tablets (quantity 60). The contract is structured as a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and will be performed in Park Ridge, Illinois. This award was issued without a set-aside designation, allowing the woman-owned small business to compete on an unrestricted basis within the...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $8,622.72 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xtandi 40 mg capsules (120 count). This delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, carries no set-aside designation, allowing the vendor to compete on an unrestricted basis despite its small business status....
- On September 16, 2025, the Defense Logistics Agency awarded a delivery order valued at $8,339.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg, an oral medication used in oncology treatment. This firm fixed-price delivery order, issued without a set-aside designation, represents a single issuance under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The performance location is...
- The Defense Logistics Agency awarded a delivery order valued at $4,311.35 to DMS Pharmaceutical Group Inc. for 120 capsules of Xtandi 40 mg on February 13, 2025, with an ultimate completion date of February 14, 2025. This firm fixed-price delivery order was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the prime contractor. The company will perform the delivery from...